Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

All Content

  • 1
    News

    FDA OKs Pfizer COVID booster for 65 and over, those at high risk

    September 23, 2021

    Emerging evidence shows that booster doses of the Pfizer vaccine cause front-line immune defenders — called binding antibodies — to roughly triple soon after a person gets the third shot.

  • News

    Should hospitalists use albumin to treat non-SBP infections in patients with cirrhosis?

    September 22, 2021

    Study data suggest that albumin may be beneficial in improving renal and circulatory function.

  • 1
    News

    Decline in child COVID may signal end of latest surge

    September 21, 2021

    United States saw fewer cases and fewer admissions among children, but also fewer vaccinations.

  • News

    Nurses ‘at the breaking point,’ consider quitting due to COVID issues: Survey

    September 21, 2021

    “Hospitals can have all the beds and all the rooms and all the equipment they want, but without nurses and others at the front lines to provide that essential care, none of it really matters.”

  • 1
    Opinion

    Embedding diversity, equity, inclusion, and justice in hospital medicine

    September 21, 2021

    Hospitalists have significant work ahead to ensure that we develop and maintain a diverse, equitable, and inclusive workforce.

  • 1
    News

    Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems

    September 21, 2021

    In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it improved specificity for intermediate-high–risk PE.

  • News

    COVID-19 claims more than 675,000 U.S. lives, surpassing the 1918 flu

    September 21, 2021

    In some ways, the United States has failed to learn from the mistakes of the past.

  • 1
    News

    EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition

    September 20, 2021

    Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.

  • 1
    News

    Navigating parenthood as pediatricians

    September 20, 2021

    There are numerous challenges for hospitalists who are parents because of poor parental leave policies in the United States.

  • News

    Moderna vaccine more effective than Pfizer and J&J

    September 20, 2021

    “Understanding differences in [vaccine effectiveness] by vaccine product can guide individual choices and policy recommendations regarding vaccine boosters.”

Previous1 … 17 18 19 20 21 … 861Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences